Effect of extracorporeal low-density lipoprotein elimination on circulating cell adhesion molecules in patients with hypercholesterolemia

American Journal of Cardiology

Volumn 87, Issue 9, 2001, Pages 1111-1113

  Richter, Volker ^a,c   Rassoul, Fausi ^a   Reuter, Wolfgang ^b   Purcz, Thomas ^b   Julius, Ulrich ^d   Gläser, Volkmar ^e   Hentschel, Bettina ^c   Wagner, Oswald ^a  

^a Institute of Clinical Chemistry and Pathobiochemistry   (Germany)

^b Department of Internal Medicine IV ^*  (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e Childrens Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ATORVASTATIN; CELL ADHESION MOLECULE; CYTOTOXIC AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL CIRCULATION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TREATMENT OUTCOME;

BLOOD COMPONENT REMOVAL; CELL ADHESION MOLECULES; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOGLOBULINS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 0035328165     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01473-4     Document Type: Article

References (19)

1. Cell adhesion molecules in cardiovascular disease and its risk factors - What can soluble levels tell us?
2. Circulating adhesion molecules and severity of coronary atherosclerosis
3. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in atherosclerosis and incident coronary heart disease cases
4. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin
5. Relationship between insulin resistance, soluble adhesion molecules, and mononuclear cell binding in healthy volunteers
6. Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules
7. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: Possible role of oxidative stress
8. Putative role of adhesion molecules in metabolic disorders
9. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities
10. Circulating cell adhesion molecules in patients with risk factors for atherosclerosis
11. Cellular adhesion molecules and atherogenesis
12. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia
13. New indices of ischemic heart disease and aging: Studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease
14. Levels of soluble cell adhesion molecules in patients with dyslipidemia
15. Cell adhesion molecules - Can they be used to predict coronary artery disease in patients with familial hypercholesterolaemia?
16. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholestrolemia
17. Improvement of coronary vasodilatation capacity through single LDL apheresis
18. Lipid apheresis by hemoperfusion: In vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood
19. DALI - The first human whole-blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: Procedure and clinical results